Title: Global Artificial Organs Market | Share, Size ,Trends And Forecast Research Report Till To 2022
1 Global Artificial Organs Market Stimulated by
Unavailability of Organ Donors
Copyright IMARC. All Rights Reserved
2About IMARC Group
Report Description
IMARC is a leading advisor on management
strategy and market research worldwide. We
partner with clients in all sectors and regions
to identify their highest-value opportunities,
address their most critical challenges, and
transform their businesses. IMARCs information
products include major market, scientific,
economic and technological developments for
business leaders in pharmaceutical, industrial,
and high technology organizations. Market
forecasts and industry analysis for
biotechnology, advanced materials,
pharmaceuticals, food and beverage, travel and
tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3Report Description and Highlights
Report Description
Global Artificial Organs Market Stimulated by
Unavailability of Organ Donors The global
artificial organs market has been witnessing a
healthy growth. This can be attributed to ageing
population, rising number of road accidents,
scarcity of organ donors, advancements in the
technology, etc. The latest report by IMARC
Group, titled Artificial Organs Market Global
Industry Trends, Share, Size, Growth, Opportunity
and Forecast 2017-2022, finds that the global
artificial organs market reached a value of more
than US 12 Billion in 2016. Artificial organs
are man-made electrical devices that are
integrated into a human body so as to replace a
damaged or missing natural organ. They are
composed of plastic that is seeded with stem
cells from the transplant recipient, due to which
the bodys immune system does not reject the
artificial organ. These bio-artificial devices
can temporarily or permanently substitute organs
and provide support for restoring a specific
function so that the patient can heal rapidly.
Artificial organs include pacemaker, artificial
heart and artificial substitutes for missing
limbs or performing kidney functions. Request
Sample of the Report http//www.imarcgroup.com/r
equest?typereportid833flagB
4Report Description and Highlights
Report Description
5Report Description and Highlights
Report Description
- Highlights of the global artificial organs
market - Ageing population and growing cases of chronic
diseases are major growth driving factors. - Artificial kidney represents the most popular
product type, leading the artificial organs
market. - North America represents the largest market,
holding the majority of the global share. - A rise in geriatric population, growing
prevalence of chronic diseases and a surge in the
number of people suffering from organ failures
and limb amputation are the major growth-inducing
factors for the artificial organs market.
Further, unavailability of organ donors at the
time of requirement coupled with growing public
awareness about the advancements in the
healthcare sector are contributing to the growth
of the market. As a result of rising incidences
of road accidents and injuries leading to
amputations, the demand for artificial organs has
further increased. Furthermore, advancements in
technological innovations to develop affordable
artificial organs are also projected to aid the
market growth. According to the report, the
market is expected to reach a value of more than
US 20 Billion by 2022, exhibiting a CAGR of
nearly 7 during 2017-2022. - Read full report _at_ http//www.imarcgroup.com/artif
icial-organs-market
6Report Description and Highlights
Report Description
- On the basis of type, artificial kidney
represents the largest product type. Other major
product types include artificial heart, cochlear
implants and artificial pancreas. On the basis of
region, North America represents the largest
market for artificial organs, accounting for the
majority of the total global share. Other major
regions include Europe, Asia-Pacific, Latin
America, and Middle East and Africa. On
evaluating the competitive landscape of the
market, it is found that the key players include
Abiomed, Inc., Heartware International, Inc.,
Edwards Lifesciences Corp, Boston Scientific
Corporation and Cochlear Limited. - The report by IMARC Group has examined the
global artificial organs market on the basis of - Type
- Artificial Kidney
- Artificial Heart
- Artificial Pancreas
- Cochlear Implants
- Others
- Region
- North America
-
-
7Report Description and Highlights
Report Description
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Major manufacturers
- Abiomed, Inc.
- Heartware International, Inc.
- Edwards Lifesciences Corp
- Boston Scientific Corporation
- Cochlear Limited
-
- Browse More Related Report http//www.imarcgroup
.com/categories/healthcare-market-research-reports
8Report Description and Highlights
Report Description
2017 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
9 Contact Us